Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells (vol 467, pg 19, 2018)

Guzova Julia A.; Primiano Michael J.; Jiao Aiping; Stock Jeffrey; Lee Chiachin; Winkler Aaron R.; Hall J. Perry

首页> 外文期刊>Journal of Immunological Methods >Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells (vol 467, pg 19, 2018)

【24h】

Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells (vol 467, pg 19, 2018)

机译：优化的协议，用于研究NLRP3炎症和对未分化的THP1细胞CP-453,773的潜在目标的评估（Vol 467，PG 19，2018）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Immunological Methods》 |2019年第2019期|共1页
作者
Guzova Julia A.; Primiano Michael J.; Jiao Aiping; Stock Jeffrey; Lee Chiachin; Winkler Aaron R.; Hall J. Perry;
展开▼
作者单位

Pfizer Inflammat &

Immunol Res Unit Cambridge MA 02139 USA;

Pfizer Inflammat &

Immunol Res Unit Cambridge MA 02139 USA;

Pfizer Inflammat &

Immunol Res Unit Cambridge MA 02139 USA;

Pfizer Dept Discovery Sci Groton CT 06340 USA;

Pfizer Dept Discovery Sci Groton CT 06340 USA;

Pfizer Inflammat &

Immunol Res Unit Cambridge MA 02139 USA;

Pfizer Inflammat &

Immunol Res Unit Cambridge MA 02139 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献

1. Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells (vol 467, pg 19, 2018) [J] . Guzova Julia A., Primiano Michael J., Jiao Aiping, Journal of Immunological Methods . 2019,第期

机译：优化的协议，用于研究NLRP3炎症和对未分化的THP1细胞CP-453,773的潜在目标的评估（Vol 467，PG 19，2018）
2. miR-19-5p Enhances Tumorigenesis in Human Colorectal Cancer Cells by Targeting TSPYL5 (vol 37, pg 23, 2018) [J] . Huang, Luo DNA and Cell Biology . 2018,第4期

机译：miR-19-5p通过靶向Tspyl5（Vol 37，2018年第23,23,208,33,2008）增强人结肠直肠癌细胞中的肿瘤鉴定
3. VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics (vol 19, pg 259, 2018) [J] . Andrewa J. A., Cudkowicz M. E., Hardiman O., Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration . 2018,第3a4期

机译：活力-ALS，Tirasemtiv的III期试验，一种选择性快速骨骼肌肌钙蛋白激活剂，作为肌萎缩侧面硬化症患者的潜在治疗：研究设计和基线特征（Vol 19，PG 259,2018）
4. Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19 [O] . Adnan Shah 2020

机译：新型冠状病毒诱导的NLRP3炎性体激活：治疗COVID-19的潜在药物靶标。
5. Application of Advanced Microscopic Methods to Study the Interaction of Carboxylated Fluorescent Nanodiamonds with Membrane Structures in THP1 Cells: Activation of Inflammasome NLRP3 as the Result of Lysosome Destabilization [O] . -1

机译：高级微观方法研究羧化荧光纳米金刚胺与膜结构在THP1细胞中的相互作用：溶血体稳定化导致炎炎症组织的活化

Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells (vol 467, pg 19, 2018)

著录项

相似文献

相关主题

期刊订阅